InterVivo Solution’s mission is to develop and provide translational animal models and transformative research services in an effort to improve the clinical success of new drugs. InterVivo provides a natural aging canine model of human diseases with a particular emphasis on AD progression, cancer, osteoarthritis, obesity and metabolic disorder. In addition to drug metabolism and pharmacokinetics screening and IND-enabling services, the company provides rodent models of cognitive function, obesity and addiction, pain and epilepsy, and Parkinson’s disease. State-of-the-art Imaging services and bioanalytical support is also provided.
View Top Employees from InterVivo SolutionsWebsite | http://www.intervivo.com |
Revenue | $3 million |
Employees | 27 (27 on RocketReach) |
Founded | 2010 |
Phone | (416) 677-6085 |
Fax | (416) 920-1019 |
Technologies |
JavaScript,
HTML,
Twitter
+10 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Pharmaceutical, Business Services, Health Care |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular InterVivo Solutions employee's phone or email?
The InterVivo Solutions annual revenue was $3 million in 2024.
Mark Duxon is the CEO of InterVivo Solutions.
27 people are employed at InterVivo Solutions.
InterVivo Solutions is based in Fergus, Ontario.
The NAICS codes for InterVivo Solutions are [54171, 541714, 541, 5417, 54].
The SIC codes for InterVivo Solutions are [87, 873].